SUVN-I6107
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for SUVN-I6107, covering 2026-04-07 to 2026-04-07. Get the full timeline:
Most recent: Clinical Trial Update: Safety, Tolerability, Pharmacokinetics And Pharmacodynamics of SUVN-I6107 In Healthy Participants [Phase 1]